COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities

CJC-1295 10 mg

$75.00

CJC-1295, a synthetic growth-hormone-releasing hormone (GHRH) analog, 10 mg lyophilized. For research purposes only.

Get the Pen version

Prefer the dual-chamber pen? Leave your email and we’ll let you know as soon as the pen version of this compound is available.

View Certificate of Analysis Independent third‑party lab report · PDF

Description

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) designed for an extended duration of action.

Commonly explored in research for:

  • Stimulation of endogenous growth-hormone (GH) release
  • Downstream IGF-1 production and the GH/IGF-1 axis
  • Growth-hormone pulse amplitude and somatotroph signalling
  • Comparative studies of long-acting secretagogues

Supplied as 10 mg lyophilized powder for reconstitution.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About CJC-1295

Classificationstr
CAS Registry863288-34-0
Molecular Mass3647.2
Residue Countstr
Chain SequenceTyr-D-Ala-Asp-Ala-Ile
Molecular FormulaC165H269N47O46
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Journal of Clinical Endocrinology & Metabolism

CJC-1295: A long-acting growth hormone releasing factor

2004 • PMID: 15181096

Teichman SL, Neale A, Lawrence B

Read Paper ↗
Clinical Pharmacology & Therapeutics

Pharmacokinetics of CJC-1295

2005 • PMID: 15961967

Lawrence B, Neale A, Teichman SL

Read Paper ↗
Growth Hormone & IGF Research

CJC-1295 and its effects on growth hormone release

2006 • PMID: 16563552

Neale A, Teichman SL, Lawrence B

Read Paper ↗